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The medicinal plants Annona senegalensis Pers. and Allophylus africanus P Beav. are 
traditionally used  for the treatment of cancer in Tanzania. However, there is no scientific 
documentation on their therapeutic effectiveness. To evaluate the anticancer potential of A. 
senegalensis and A. africanus plant species from Tanzania, stem bark of the two plants were 
collected from Ugweno village at Kilimanjaro, Tanzania. Pulverized plant materials were 
soaked  in dichloromethane/methanol (DCM:MeOH), petroleum ether (PE), DCM, ethyl 
acetate (EtOAC), MeOH and water to obtain DCM-MeOH, PE, DCM, EtOAC and MeOH 
extracts respectively. Anticancer activity against breast (HCC 1396), throat (HEp- 2) and 
colon (CT 26) cancer cell lines was assessed by the MTT cell viability assay. Results showed 
that anticancer activity varied between plant extracts and the cancer cell lines. The highest 
anticancer activity was achieved with A. senegalensis petroleum ether extract against HEp-2. 
The findings justify traditional use of A. senegalensis and A. africanus in treatment of cancer. 
This study found petroleum ether extract of A. senegalensis to have high potential for 
development of an anticancer agent against throat cancer. Further studies involving the 
isolation of pure anticancer compounds from the two plants are recommended to elucidate 
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1.1. Background Information 
Cancer is one of the most fatal diseases worldwide (Max Parkin, Bray, Ferlay, & Pisani, 
2005; Biemar & Foti, 2013). Around one third of deaths from cancer are due to the five 
leading behavioral and dietary risks, which are: high body mass index, low fruit and 
vegetable intake, lack of physical activity and the use of tobacco and alcohol (Prakash, 
Kumar, Kumar, & Ajeet, 2013). In 2012, the worldwide burden of cancer rose to an estimated 
14 million new cases per year, a figure expected to rise to 22 million annually within the next 
two decades. Over the same period, cancer deaths were predicted to rise from an estimated 
8.2 million annually to 13 million per year. During this period, lung  cancers  were 
responsible for the highest death, about 1.6 million (19.4%) followed by liver (0.8 million, 
9.1%) and gastric (0.7 million, 8.8%) (World Health Organization (WHO), 2014).  
Cancer treatments approach involve chemotherapy, surgery, radiation therapy, 
immunotherapy, targeted therapy, and hormonal therapy, of which are associated with side 
effects (Baskar, Lee, Yeo, & Yeoh, 2012; WHO, 2014). Of all treatments, chemotherapy is 
the most effective but due to high dose requirements it kills normal cells hence causing side 
effects such as fatigue, nausea, hair loss, vomiting, loss of appetite, constipation, anemia, 
diarrhea etc, (Aslam et al., 2014; Conklin, 2004). Therefore, patients’ preferences to use 
herbal medicines as alternative source of treatment has gained attention in many parts of the 
world including Tanzania (Priya, Priya, Kotakadi, & Josthna, 2015). According to the 
Institute of Traditional Medicine at Muhimbili National Hospital (MUHAS), Tanzania is 
estimated to have over eighty thousands traditional healers with varying specialties and they 
play a crucial role of providing primary health care. It was  reported that more than 60 % of 
the population in Tanzania depends on traditional medicines for management of various 
diseases (Kisangau, Lyaruu, Hosea, & Joseph, 2007).  
Plants produces secondary metabolites which has been reported to possess therapeutic effect 
which can be tolerated by the body (Priya et al., 2015). Apart from that, they could be 
combined to obtain synergism, which would enhance efficacy while reducing drug resistance 




Soonthornchareon, 2008). This property has allowed traditional healers, including here in 
Tanzania to use combinations of medicinal plants to cure various diseases. According to the 
information obtained through carrying out interviews of traditional healers and communities, 
Annona senegalensis and Allophylus africanus are among of medicinal plants used in 
treatment of cancer in Tanzania. Annona senegalensis is reported to be used by local 
populations all over Africa in treatment of various diseases such as respiratory infections, 
guinea worms, pneumonia, diarrhea, gastroenteritis, snake bites, toothache and dizziness 
(Awa, Ibrahim, & Ameh, 2012). Allophylus africanus is used traditional by some part of 
Africa in treatment of cough, fever, dysentery, and malaria (Sofidiya et al., 2012). The stem 
bark of the two plants have been claimed to be used by Pare tribe from Ugweno village of 
Kilimanjaro region in Tanzania for the treatment of different types of cancer such as throat, 
breast, liver, cervical and colon cancer. However, unlike in several other African countries 
(Graham, Quinn, Fabricant, & Farnsworth, 2000; Awa et al., 2012; Oladosu, Balogun, & 
Ademowo, 2013), the scientific proof of the therapeutic effectiveness of the plants has not 
been documented in Tanzania. In an attempt to fill the gap, this study was implemented to 
evaluate the anticancer activity of the aforementioned plants. 
1.2. Statement of Research Problem and Justification 
Cancer is the  leading cause of death worldwide (Deshmukh et al., 2017). Various approaches 
have been employed to treat and control cancer but all of them have been associated with side 
effects. Therefore herbal medicines have been used as alternative source of treatment since 
they are available and are not harmful as conventional medicine (Yasser, 2016).  
Annona senegalensis and Allophylus africanus are medicinal plant that are claimed to be used 
in treatment of cancer in Tanzania, but the scientific evidence on performance of these plants 
against cancer has not been documented. However, the scientific evidence in treatment of 
various diseases including cancer, malaria and bacterial diseases  have been reported from 
different part of Africa (Ajaiyeoba, Falade, Ogbole, Okpako, & Akinboye, 2006; Sofidiya et 
al., 2012; Mustapha, 2013). Regarding the studies which revealed the effect of ecological 
variation on the production of active substances in the medicinal plants (Devkota, 
Dall’Acqua, Jha, & Innocent, 2010; Liu, Liu, Yin, & Zhao, 2015), there is a need of 




Since the scientific information for the plants’ therapeutic value against cancer is limited in 
Tanzania, this study envisaged evaluating anticancer potentials of A. senegalensis and A. 
africanus against throat (HEp-2), breast (HCC 1396) and colon (CT 26) human cancer cell 
lines.  
1.3. Objectives 
1.3.1. General Objective 
To determine the effects of Annona senegalensis and Allophylus africanus plant extracts on 
human breast (HCC 1396), throat (HEp-2) and colon (CT 26) cancer cell lines.  
1.3.2. Specific Objectives 
(i) To determine phytochemical composition of A. senegalensis and A. africanus plant 
extracts. 
(ii) To determine in vitro anticancer activity of A. senegalensis and A. africanus against 
selected human cancer cell lines. 
(iii) To determine cytotoxic activity of A. senegalensis and A. africanus against VERO 
cell lines.  
1.4. Hypothesis 
(i) The plants have no phytochemical compounds. 
(ii) The plants have no anticancer effect against selected cancer cell lines.  
(iii) The plants have no cytotoxic activity against VERO cell line. 
1.5. Significance of the Study 
This study will contribute evidence to the existing traditional knowledge for the treatment of 
cancer. Also, will provide opportunity for further studies which may lead to development of 







2.1. Overview  
Cancer is a malignant condition in which the spread of abnormal cellular growth become 
uncontrollable (Priya et al., 2015). It is commonly due to mutation of two genes which are 
oncogenes and tumor -suppressor genes. Oncogenes normally promote cell growth, however 
when overexpressed they transform healthy cells into cancer cells. Tumor- suppressor genes 
normally restrain growth so when under expressed allow inappropriate cell division which 
can facilitate carcinogenesis (Boik, 2001). The mutation can arise due to several factors such 
as tobacco use, lack of physical exercise, unhealthy diet, alcohol consumption, automobile 
exhaust pollutant, UV radiation and bacterial or viral infection (Prakash et al., 2013). This 
mutation causes DNA damage which results to precancerous cells that divides to produce 
daughter cells having   the ability to invade and metastasize other tissues (Idikio, 2011). 
2.2. Cancer Barden 
Cancer is the second leading cause of death in high-income countries following 
cardiovascular diseases but the third leading cause of death in low- and middle-income 
countries, following cardiovascular diseases and infectious diseases (WHO, 2014). According 
to the International Agency for Research on cancer, lung cancer is the most diagnosed and 
leading cause of cancer death. This is followed by breast, prostate and colorectal cancer 
(Delancey, Jemal, & Ward, 2010). Global, the type of cancer and distribution is economically 
dependent. Cancer burden is increasing in developing countries due to population growth, 
changing of lifestyles and aging. The number of cases is expected to increase most in middle 
and low countries to 24 million in 2050 which would be twice the number in 2002 which was 
10.8 million (Siegel, Miller, & Jemal, 2018). 
2.3. Cancer Chemoprevention 
Cancer cells rely on processes that are fundamentally similar to the processes used by normal 
cells hence become hard to kill without damaging normal cells.  The best way to inhibit a 




(Boik, 2001). Chemotherapy is the most effective and widely used treatment in most types of 
cancer though there are other cancer treatments approach such as surgery, radiation therapy, 
immunotherapy, targeted therapy, and hormonal therapy (Baskar et al., 2012). However, it is 
none specific as it affects both cancer cells and normal cells resulting to side effects (Conklin, 
2004). According to the study conducted in Pakistan, the most frequently reported of these 
side effects including weakness, fatigue, nausea, hair loss and vomiting (Prakash et al., 
2013). Other prominent side effects include mouth sores, dry mouth, temperature reaction, 
constipation, mood swings, weight loss and numbness whereas diarrhea, abdominal cramps 
and memory impairment is less commonly occurring side effects. These side effects limit the 
efficiency of chemotherapy. So, there is a need of searching alternative cancer treatment with 
minimum or no side effects (Aslam et al., 2014). 
2.4. Plant Phytochemicals and Cancer Prevention 
For many years herbal medicines have been used and are still being used in developing 
countries as the primary source of medical treatment (Yasser, 2016). Since 1997 medicinal 
plants had proven scientifically to associate with fewer side effects by National Institute of 
Health of United States. Medicinal plants produces secondary metabolites which are used to 
perform important biological functions, and to defend against attack from predators such as 
insects, fungi and herbivorous (Ajuru et al., 2017). These metabolites have  been reported to 
possess therapeutic effect which are non-toxic to normal cells hence not harmful to the body 
(Greenwell & Rahman, 2015). The metabolites including tannins, alkaloids, terpenoids,  
flavonoids and saponins which  contain good immunomodulatory and antioxidant properties 
which lead them to be potential anticancer drugs.  
Tannins possess antioxidant and haemostatic properties. Also has a tendency of reducing the 
digestibility of proteins in foods. Alkaloids have been reported to have a wide range of 
pharmacological properties such as antimalarial, antiasthma and anticancer properties. It was 
also reported to have antibacterial, anti-hyperglycemic and analgesic activity (Bako, Bakfur, 
John, & Bala, 2005). Terpenoids protect plants from their natural enemies and play role as 
growth regulator. In addition have medicinal properties such as antimalarial, anti-ulcer, 
antimicrobial and anticancer. Flavonoids have reported to possess antioxidant, anti-
inflammatory, anti-allergic, anti-carcinogenic, anti-microbial, and anti-viral activities (Ajuru 




tract inflammations. They also have been reported to have anti-diabetic and anti-fungal 
properties (Yessuf, 2015). Phytochemicals can be classified by function as an individual 
compound and may have more than one biological function (Table 1) (Saxena, Saxena, 
Nema, Singh, & Gupta, 2013). Plant-derived drugs are preferred for cancer treatment as they 
are natural and available (Madhu, Sailaja, Satyadev, & Satyanarayana, 2016). 
 
Table 1: Bioactive and disease preventing phytochemicals present in plant 




gums, mucilages, pectins, 
lignins 
Water holding capacity, delay in 
nutrient absorption, binding toxins 





Inhibitors of micro-organisms, 
reduce the risk of fungal infection 
Antioxidants Polyphenolic compounds, 
flavonoids, carotenoids, 
tocopherols, ascorbic acid 
Oxygen free radical quenching, 
inhibition of lipid peroxidation 
Anticancer Carotenoids, polyphenols, 
curcumine, Flavonoids 
Inhibitors of tumor, inhibited 
development of lung cancer, anti-
metastatic activity 
Detoxifying Agents Reductive acids, tocopherols, 





Inhibitors of procarcinogen 
activation, inducers of drug binding 
of carcinogens, inhibitors of 
tumourogenesis 
Other Alkaloids, terpenoids, volatile 





(Sexane et al., 2013) 
2.5. Commonly Medicinal Plants Used in Tanzania 
More than sixty percent of the population in Tanzania depends on traditional medicines for 
management of various diseases including cancer (Kisangau et al., 2007). Medicinal plants 
play an important role in providing primary health care to the rural and urban communities of 
Tanzania. It also provides a source of income to traditional healers within the country (Kitula, 
2007). Apart from that, it was reported that, the use of traditional medicine in Tanzania is 
associated with belief in the power of medicinal plants to bring good health during pregnancy 




Also are used as contraceptives for birth control. Many ethnic groups such as Pare, Haya, 
Mbulu etc. have been practicing medicinal plants for treatment of various diseases. These 
medicinal plants include A. senegalensis and A. africanus which are used in different regions 
of the country (Matata, Ngassapa, Machumi, & Moshi, 2018). According to the study 
conducted by Wenzel (2011), the most  reason why patients opt for the use of traditional 
medicines is because treatment at the hospital did not heal them. However, the findings 
indicated that a large majority of the patients surveyed believed both traditional and western, 
although traditional medicine is often not the first choice. 
2.6. Annona senegalensis 
Annona senegalensis, popular known as African custard apple or wild custard apple is a 
shrub that belongs to the family Annonaceae and is usually found growing in semi-arid to 
sub-humid regions of Africa (Okoli et al., 2010). It is native and widely distributed in Africa 
(Okoye, Akah, Ezike, Omeje, & Odoh, 2012). In Tanzania, it is known as Mkisha by Pare 
tribe of Kilimanjaro region. Stem barks of A. senegalensis are claimed by this community to 
be used to cure several types of cancer such as liver, cervical, breast and colon cancer. The 
plant has reported scientifically from different part of Africa to possess antimicrobial, 
antioxidant, antiparasitic, anti-inflammatory, anticonvulsant, antimalarial, trypanocidal, anti-
snake venom, anti-nociceptive, and anthelmintic activities (Ajaiyeoba et al., 2006; Awa et al., 
2012; Mustapha, 2013). It has also has been reported to be   effective against cervical, skin 





Figure 1: Annona senegalensis 
 
2.7. Allophylus africanus 
Allophylus is the largest genus of a family Sapindaceae (Balogun, Oladosu, & Liu, 2016). 
This genus is widely distributed in tropical and subtropical regions of the America, Africa, 
Asia, Indian Archipelago and Pacific (Chavan & Gaikwad, 2016). Allophylus africanus is 
commonly called Mlunguu by the Pare tribe in Tanzania. Its stem barks are used in treatment 
of throat and breast cancer. Scientifically, it has reported to have strong antimalarial (Oladosu 
et al., 2013; Balogun, Oladosu, & Liu, 2014), antibacterial and antioxidant activities 
(Sofidiya et al., 2012). One of the species from the same genus, Allophylus cobbe, was 
confirmed to have anticancer activity against human prostate cancer cell lines (Ghagane, 















MATERIALS AND METHODS 
3.1. Plant Collection 
Fresh stem barks of each plant were collected from Ugweno village in Kilimanjaro region of 
Tanzania. This is mountainous area comprising of evergreen rainforest assemblages. The 
plants were collected from traditional healers and identified by a taxonomist at the Tropical 
Pesticides Research Institute (TPRI) herbarium located in Tanzania where specimen were 
deposited after being assigned voucher specimen numbers EB.01 and EB.02 for A. 
senegalensis and   A. africanus respectively. 
       





Figure 5: Sampling area at Ugweno village. 
3.2.  Extraction Methods 
Plant material were air dried and ground to fine powder using an electric blender then stored 
at room temperature until used. Extraction was done using six solvents for each plant making 
a total of twelve extracts. Extraction was done using dichloromethane/ methanol 
(DCM:MeOH) at a ratio of 1:1 (Fouche et al., 2008). About 500 g of each plant powder were 
soaked completely into a mixture of 1 L of DCM and 1 L of MeOH for 72 h. The extract 
solutions were filtered and concentrated using a rotary evaporator. Extraction was done 
sequentially with petroleum ether (PE), DCM, ethyl acetate (EtOAC) and MeOH starting 
from least polar to most polar solvent respectively. For sequential extraction, 500 g of each 
plant powder were soaked in 1 L of petroleum ether, and then the filtrate re-soaked in the rest 
of solvents sequentially. All solvents were filtered after every 48 h and extracts concentrated 
through the vacuum using a rotary evaporator (Kigondu et al., 2011). The remaining powder 
material were further extracted in aqueous medium by soaking 500 g of fine powder of each 
plant material in 1 L of water at 60 ◦C for 60 min. The filtrate were then freeze dried to free 





3.3. Study Design 
In vitro laboratory based (pre-clinical) experimental study design method was used. 
3.4. Qualitative Phytochemical Screening 
Qualitative phytochemical screening was done to determine secondary metabolites which 
were present in the Annona senegalensis and Allophylus africanus extracts. The screening 
was  done as described by Ajuru et al. (2017). Secondary metabolites tested were alkaloids, 
tannins, glycosides flavonoids, saponins and terpenes.   
3.4.1. Test for Alkaloids 
Alkaloids were tested by pouring 2 ml of the extracts into a watch glass and followed by 
addition of 1% of hydrochloric acid and three drops of Mayer’s reagent. The formation of a 
white precipitate indicated the presence of alkaloids. 
3.4.2. Test for Saponins 
Saponins were tested by mixing 2 ml of the extracts with 2 ml of distilled water and the 
mixture was shaken vigorously. After shaking the test tube was allowed to stand. Formation 
of a persistent layer of foam indicated the presence of saponins.  
Figure 7: Plants powder 
soaked into respective 
solvents. 
Figure 6: Solvent filtration 




3.4.3. Test for Flavonoids 
Flavonoids were tested by mixing 2 ml of the extracts with 5 ml of dilute ammonia in a test 
tube. Then 2 ml of concentrated sulphuric acid was added and shaken. Formation of intense 
yellow color indicated the presence of flavonoids. 
3.4.4. Test for Glycosides 
Glycosides were tested by mixing 2 ml of the extracts with 2 ml of chloroform. Then was 
followed by addition of 2 ml of sulphuric acid and mixed well. Formation of a brown color 
indicated the presence of glycosides.   
3.4.5. Test for Terpernoids 
Terpernoids were tested by adding 2 ml of chloroform into 2 ml of the plant extracts and 
shaken vigorously. Then, 2 ml of concentrated sulphuric acid was added and heated for 2 
min. Formation of grey color indicated presence of terpernoids. 
3.4.6. Test for Tannins 
Tannins were tested by adding 5 ml of distilled water into 2 ml of the plant extracts and 
heated to boil. Two percent of iron chloride was then added. A green precipitate indicated the 
presence of tannins. 
3.5. Determination of Anticancer Activity  
3.5.1. Cell Lines Culturing 
The following cancer cell lines were used in this study: CT 26 (Colon cancer), HEp -2 
(Throat cancer), and HCC 1396 (Human breast cancer). VERO P23 (African green monkey 
kidney) was used as the normal cells for reference purpose. The cell lines were originally 
obtained from the American Type Culture Collection (ATCC) and sub-cultured at the Center 
for Traditional Medicine and Drug Research (CTMDR), Kenya Medical Research Institute 
(KEMRI). The cell lines were cultured in Dulbecco Modified Essential Medium (DMEM) 
supplemented with 10% Fetal Bovine Serum (FBS), 1% L-glutamine and 100 µg/ml of 




3.5.2. Methyl Tetrazolium Bromide (MTT) Assay 
(i) Principal 
This is a colorimetric assay based on cleavage of tetrazolium salt to form a blue formazan 
product by enzymatic activity of mitochondria succinate dehydrogenase enzymes in living 
cells. The Formazan formed is direct proportional to the number of the living cells during 
MTT exposure. It is measured spectrophotometrically in an optical density reader. The 
activity of the enzyme to produce formazan is directly proportional to the level of cell 
viability and inversely proportional to the level of cell inhibition (Twentyman & Luscombe, 
1987).  
(ii) Procedure  
Upon attainment of confluence, cells were washed with saline phosphate buffer and harvested 
by trypsinization. The number of viable cells was determined using Trypan blue exclusion 
method (cell density count) using a hemocytometer. They were then seeded in 96 well plates 
at a concentration of 2 x 105 cell/ml in 100 µl per well and incubated for 24 h at 37◦C in a 5% 
CO2 and 95% humidity for 24 h to let cells adhere onto to the surface of the wells. Zero point 
zero one gram of each extracts was then weighed and diluted to a concentration of 100 µg/ml. 
Fifteen micro litres of each extract was then added onto row H of the plate. This was 
followed by three folds serial dilution to get different concentrations from 100 µg/ml, 33.33 
µg/ml, 11.11 µg/ml, 4.0 µg/ml, 1.33 µg/ml, 0.44 µg/ml and 0.146 µg/ml from row H to B 
respectively. Row A was left as a negative control. Doxorubicin, a standard drug  for cancer 
treatment was used as the positive control (Wang et al., 2004). All concentrations were 
replicated two times for each plant extracts, then incubated for 48 h at 37 ◦C in a 5% CO2 and 
95% humidity. After 48 h incubation, 10 µl of MTT dye was added to each well and 
incubated for 2 h. The insoluble formazan product which is directly proportional to the 
number of living cells present during MTT exposure was then dissolved by 50 µl DMSO. 
Absorbance was then read at a wavelength of 540 nm and a reference wavelength of 720 nm 
using ELISA Reader (MULTSKAN GO Thermo scientific, USA). The effect of the plant 
extracts on the cells was expressed as IC50 values (drug concentration inhibiting cell growth 





3.6. Determination of Percentage Inhibition 
The percentage cells inhibition after treatment was calculated using the formula developed by 
Patel, Gheewala, Suthar and Shah (2009)  as follows; 
                  Proliferation rate= x 100  
                  Percentage inhibition= x 100 
Where,  
At= Absorbance value of test compound (cells plus extracts)  
Ab= Absorbance value of blank (media only)  
Ac=Absorbance value of negative control (cells plus media) 
3.7. Selectivity Index (SI) 
Selectivity index is the value calculated to determine which plant extracts can select cancer 
cells and sparing normal cells. The selectivity index is corresponded to the CC50 value 
determine activity of plant extracts on VERO cells divided by the IC50 determine activity on 
cancer cells. The selectivity index was considered as interesting for values higher than three. 
                                
                           SI=  
Figure 8: Appearance of cells in 96 well 
plate after adding MTT dye 
Figure 9: Appearance of cells in 96 well 
plate after incubated for 2 h 




3.8. Data Management and Statistical Analysis 
Raw data were entered into excel data sheets where by the concentrations inhibiting growth 
of the cells by 50% (IC50) were calculated. A dose response curve was plotted and used to 
determine the (IC50) values.  The IC50 data were subjected to One Way Analysis of Variance 
(ANOVA, MiniTab Version 18) to determine differences (p≤0.05) among plant extracts IC50. 
Multiple comparison of IC50 was done by Tukey test. Experimental results are expressed as 
mean ± SEM and all measurements were in duplicate. 
The data generated from phytochemical screening of A. senegalensis and A. africanus 
extracts were qualitative and tabulated.   
3.9. Ethical Consideration 
Samples were collected following permission from traditional healers and owners of the 
farms at Pare Mountain. Prior to commencement of study, clearance was sought from the 
Scientific and Ethics Review Unit (SERU) in KEMRI. All safety and standards laboratory 








RESULTS AND DISCUSSION 
4.1. Percentage Yields 
Annona senegalensis and Allopylus africanus were collected from Ugweno village of 
Kilimanjaro region in Tanzania and evaluated for anticancer activity. Twelve extracts were 
made by extracting the stem bark of the two plant in six solvents. The percentage yield of 
each extract is shown in Table 2. There was variation of extraction yields from 1 to 6.8% 
depending on the type of solvent used for extraction. Highest yields were obtained with 
aqueous extractions which could  be due to the high solubility of different plant compounds 
in this solvent (Senguttuvan, Paulsamy, & Karthika, 2014) 
Table 2: Extraction yield (%) of A. senegalensis and A. africanus 






AS  Pet ether 500g 5g 1.0% 
AA Pet ether 500g 6g 1.2% 
AS  DCM:MeOH 500g 25g 5.0% 
AA DCM:MeOH 500g 10g 2.0% 
AS  DCM 500g 6g 1.2% 
AA DCM 500g 8g 1.6% 
AS  Ethyl acetate 500g 9g 1.8% 
AA Ethyl acetate 500g 11g 2.2% 
AS  MeOH 500g 15g 3.0% 
AA  MeOH 500g 26g 5.2% 
AS  Aqueous 500g 34g 6.8% 
AA  Aqueous 500g 32g 6.4% 
AS: Annona senegalensis, AA: Allophylus africanus 
 
4.2. Phytochemical Screening of Plant extracts 
The twelve stem bark extracts of A. senegalensis and A. africanus, contained phytochemical 
compounds shown in Table 3 and 4. Flavonoids were found present in all extracts of both 
plants.  Flavonoids is commonly known to have antioxidant nature and it has been reported to 
have antiproliferative activity against many cancers (Widyawati, Dwi, Budianta, Kusuma, & 
Wijaya, 2014). Therefore, its presence in A. senegalensis and A. africanus extracts could be 
related with their anticancer activity. All metabolites were present in ethyl acetate extracts of 




presence of these metabolites could be related with previous researches which informed that 
ethyl acetate is semi polar solvents hence can dissolve both polar and non-polar compounds 
(Ajuru et al., 2017). The results suggested ethyl acetate as good extraction solvent for active 
phytochemical compounds from these two plant species. The absence of metabolites in other 
plant extracts  could be due to inability of these components to dissolve into respective 
solvents regarding their difference in polarity (Bandar et al., 2013). Regarding the study of 
Al-asady, Suker and Hassan (2014) which indicated that the glycoside fraction I from 
Convolvulus arvensis had more cytotoxic inhibition at 10 mg/ml against rhabdomyosarcoma 
(RD) tumour cell line in vitro after 72 h, compared with other extracts (aqueous and 
methanol), crude extracts of the leaves, stems and roots, the presence of these   
phytochemicals in the extracts could be implicated in the medicinal value of the two plants.  
   
Table 3: Phytochemical analysis of different solvent extracts of A. africanus 
Solvent Alkaloids Saponins Flavanoids Glycosides Terpenes Tannins 
Pet ether        -       -      +        -       +      - 
DCM:MeOH        +       -      +       +       +     + 
DCM        -       -      +        -       +     - 
Ethyl acetate        +      +      +       +       -     + 
MeOH        +      +      +       +       -     + 
Aqueous        +      +      +       +       -      - 
 (+) sign indicates the presence of compounds tested and (-) sign indicates the absence of 
compounds tested 
 
Table 4: Phytochemical analysis of different solvent extracts of A. senegalensis 
Solvent Alkaloids Saponins Flavanoids Glycosides Terpenes Tannins 
Pet ether        -       -      +        -       +      - 
DCM:MeOH        +       +      +       +       +     + 
DCM        +       -      +        -       +     + 
Ethyl acetate        +      +      +       +       +     + 
MeOH        +      +      +       +       -     + 
Aqueous        +      +      +       +       -      + 





4.3. Anticancer Activity of A. senegalensis and A. africanus Plant Extracts against 
HEp- 2, HCC 1396, CT 26 Cell lines. 
Generally, stem bark of A. senegalensis and A. africanus inhibited proliferation rate of the 
HCC 1396, HEp- 2, CT 26 cell lines.  All the twelve plant extracts showed different levels of 
cell growth inhibition at different concentrations against the tested cell lines. There was a 
concentration dependent cell inhibition, as the concentration of plant extracts decreased from 
100 µg/ml to 0.146 µg/ml, the percentage cell inhibition decreased (Appendix I-VI). The 
proliferation rate was lowest at 100 μg/ml in row H and highest at 0.146 µg/ml in untreated 
cells (row A) (Figure 10). These results could be compared with that of Fadeyi, Fadeyi, 
Adejumo and Okoro (2013) where by twenty four plants were screened for anticancer 
activity, and results indicated that the activity is dose dependent. No anticancer activity was 
detected to exposure of low concentration (0.5 µg/ml). 
 
Figure 10: Ninety six well plate showing the decrease of proliferation rate with decreasing of 
concentration 
4.4. Determination of IC50 of A. senegalensis and A. africanus Plant Extracts against 
HEp- 2, HCC 1396, CT 26 and VERO Cell Lines 
Concentration of plant extracts that inhibited cell growth by 50% (IC50) for the twelve plant 




classified according to the standards of the National Cancer Institute (NCI) as follows: high 
anticancer when an IC50 <20 μg/ml,  anticancer for an IC50 between 20 μg/ml to 30 μg/ml, 
moderate anticancer for IC50 between 30 μg/ml to 100 μg/ml and inactive with IC50 >100 
μg/ml (Boik, 2001). Tabulated results show that anticancer activity varied between plant 
extracts and cancer cell lines tested. The highest anticancer activity was achieved with 
petroleum ether extract of A. senegalensis against HEp-2 with IC50 value of 0.42 ± 0.09 
μg/ml. This demonstrated the efficiency of petroleum ether over the other extraction solvents 
for extracting anticancer compounds against HEp-2 from A. senegalensis stem bark. 
Comparing with phytochemical results, the unknown anticancer compound extracted with 
this petroleum ether extract could be less polar flavanoids or terpenes (Table 4). Among all 
plant extracts, the following exhibited high activity. Dichloromethane extract of A. 
senegalensis: IC50 10.41± 2.07 μg/ml and MeOH extract of A. africanus: IC50 7.33 ± 0.43 
μg/ml against HCC 1396. Petroleum ether extract of A. senegalensis: IC50 0.42 ± 0.09 μg/ml 
and DCM:MeOH extract of A. africanus: IC50 1.00 ± 0.4 μg/ml against HEp-2 cancer cells. 
Petroleum ether extract of A. senegalensis: IC50 9.19 ± 0.81 μg/ml and MeOH extracts of A. 
africanus: IC50 9.04 ± 1.05 μg/ml against CT 26 cancer cells. In this study, the aqueous 
extracts (water) which  is the common solvent used by traditional healers for extraction of 
medicinal plants due to its availability (Mekonnen & Abebe, 2017), exhibited anticancer 
activity ranging from moderate to none.  
The findings could be related with previous study by Okoye et al. (2014) which indicated that 
root bark of A. senegalensis has anticancer activity against pancreatic and cervical cancer 
cells. This study, therefore, revealed that the stem bark of the same plant species has 
anticancer activity against colon, breast and throat cancer cells. Likewise, the study support a 
previous study conducted by Sofidiya et al. (2012) which showed that A. africanus had the 











Table 5: Mean IC50 of the plant extracts on HCC 1396, HEp-2, CT 26 and VERO cell lines 
Plant extracts IC50(μg/ml) HCC 
1396 






AS   Pet Ether 21.88±2.18cd 0.42±0.09a 11.59±2.58b 39.56±1.73b 
AA  Pet Ether 41.10±1.42e 2.37±1.45a 9.19±0.81b 62.70±2.04bc 
AS  DCM:MeOH 27.41±2.28d 4.50±0.72a 54.02±4.13f >100 
AA  DCM:MeOH 12.61±1.67bc 1.00±0.41a 21.52±0.06c 78.20±1.47cd 
AS   DCM 10.41±2.07b 12.36±3.20b 12.19±2.70b 52.21±1.95b 
AA  DCM 8.76±0.43b 5.02±0.71a 19.04±0.78c 57.73±1.05b 
AS   Ethyl acetate 17.19±0.19c 12.00±1.11b 26.08±0.04d 93.33±0.67d 
AA  Ethyl acetate 18.60±0.28c 9.48±0.42b 27.61±4.57d 68.33±3.79c 
AS   MeOH 47.98±4.52f 97.12±2.88f 36.52±3.23e >100 
AA  MeOH 7.33±0.43b 25.38±2.57c 9.04±1.05b 55.72±1.00b 
AS  Aqueous 76.31±1.22g 76.20±2.38e 65.03±0.04g >100 
AA  Aqueous 28.58±0.71d 65.10±3.49d >100 >100 
 Doxorubicin 1.14±0.01a 0.21±0.04a 2.94±0.05a 10.94±0.06a 
Values are expressed as Mean±SEM. Doxorubicin was used as a positive control. The IC50 
values of the plant extracts were compared with the doxorubicin for each cell line.  Values 
that do not share a letter are significantly different (p≤0.05). AS=A. senegalensis and AA=A. 
africanus. 
Doxorubicin a standard drug for cancer treatment was used as the positive control. The 
results showed that doxorubicin was more potent than all the plant extracts with IC50 value of 
1.14 ± 0.01 μg/ml for HCC 1396, 0.21± 0.04 μg/ml for HEp- 2, and 2.94 ± 0.05 μg/ml for CT 
26. This was expected as the drug is purified as opposed to the extracts which were in crude 
form. Of particular interest, petroleum ether extract of A. senegalensis depicted high activity 
against HEp- 2 at an IC50 value of 0.42 ± 0.09 μg/ml comparing well to the reference standard 
doxorubicin. Selectivity index for the same was also high (SI = 94.19). This implied its high 
potential for development of a safe anticancer agent. Potency of plant extracts varied with 
plant species and the screened cancer cell lines. High potency (IC50 <20 μg/ml) coupled with 
high selectivity (SI>3) was observed on extracts of A. senegalensis extracted using DCM 
against HCC 1396, petroleum ether on HEp- 2 and CT 26. For A. africanus this was observed 
on DCM:MeOH against HEp- 2, MeOH against HCC 1396 and CT 26 (Table 5). This 
indicated that, the aforementioned are suitable extraction solvents for anticancer compounds 




varied levels of activity. This signified the possibility of A. senegalensis and A. africanus to 
possess both polar and non-polar compounds with anticancer activity. Regarding the variation 
on performance of plant extracts shown by the solvent used in extraction, the results 
supported previous studies which showed that, the solvent type used in extraction has effect 
on the potency of medicinal plants (Koffi et al., 2010; Dhawan & Gupta, 2016). 
4.5. Cytotoxic Activity against VERO Cell Lines and Selectivity Index 
The cytotoxicity activity was determined using VERO P23 cell lines (African green monkey 
kidney cells). The results indicated that all the plant extracts investigated were less toxic to 
VERO cells (IC50 >39 μg/ml) than the positive control, doxorubicin. Four extracts were 
observed to be inactive (>100 μg/ml) while the rest moderate with IC50 ranging between 39 
μg/ml and 100 μg/ml. The IC50 of doxorubicin on VERO cells was low (10.94 ± 0.06 μg/ml), 
this support previous study which reported that doxorubicin provide side effect against 
normal tissue (Wang et al., 2004). There was a variation of selectivity among plant extracts 
and cancer cell lines tested (Table 6). Selectivity index value >3 were considered selective for 
cancer cell line while SI values <3 were considered non selective to specific cancer cell line 
(Bézivin, Tomasi, Lohézic-Le Dévéhat, & Boustie, 2003). Most of the extracts were observed 
selective active to one cancer cell line while were not selective to the other cell lines tested. 
However, at least one extract for each plant species showed selectivity to all cancer cell lines. 
These are DCM:MeOH for A. africanus and DCM for A. senegalensis. The variation of 
selectivity could be related with different phytochemical composition in the plant extracts 
(Mwitari et al., 2018). Generally, aqueous extract of A. senegalensis was found not to be 
selective (SI<3) to any cancer cell line. This could be due to the presence of toxic compounds 
that affect the performance of active compounds (Dzoyem, Mcgaw, & Eloff, 2014). 
Petroleum ether extract of A. senegalensis depicted the highest selectivity on HEp- 2 cancer 
cell lines with SI value of 94.19. This indicated that, the extract has high potential of 





Table 6: Selectivity index of A. senegalensis and A. africanus plant extracts 
Plant extracts HCC 1396 HEp-2 CT 26 
AS   Pet Ether 1.81 94.19 3.41 
AA  Pet Ether 1.53 26.46 6.82 
AS   MeOH: DCM 3.65 22.22 1.85 
AA  MeOH: DCM 6.20 78.20 3.63 
AS   DCM 5.02 4.22 6.42 
AA  DCM 6.60 9.92 2.74 
AS   Ethyl acetate 5.43 7.78 3.58 
AA  Ethyl acetate 3.67 7.21 2.47 
AS   MeOH 2.08 1.03 2.74 
AA  MeOH 7.60 2.20 6.16 
AS   Aqueous 1.31 1.31 1.54 
AA  Aqueous 3.49 1.54 N/A 
 Doxorubicin 9.6 52.1 3.8 
N/A*; Not applicable because the test drug did not inhibit the growth of the cell AS=A. 
senegalensis and AA=A. africanus 















CONCLUSION AND RECOMMENDATIONS 
5.1. Conclusion 
This study indicated that, A. senegalensis and A. africanus have potential anticancer activity 
on throat, breast and colon cancer cells. Different solvents used for extraction showed varied 
activity and selectivity against the cancer cells tested. Petroleum ether extract of A. 
senegalensis was in particular found to have high potential for development of an anticancer 
agent against throat cancer. These findings justify the use of A. senegalensis and A. africanus 
in traditional practice. The findings also support previous studies which indicated that, 
extraction solvents used on extraction of bioactive molecules affect the performance of 
medicinal plants. 
5.2. Recommendations 
From the conclusion the following recommendations are made; 
(i) Further studies are recommended on evaluation of anticancer pure compounds from 
the active extracts. 
(ii) Evaluation of in vivo anticancer activity of A. senegalensis and A. africanus in animal 
model is recommended.  
(iii) Further studies on anti-cancer activity of petroleum ether extract of A. senegalensis 
against throat cancer can be made so as to recommend the development of anti-cancer 
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Appendix 1: Percentage cell inhibition against four cell lines by petroleum ether extracts 
Concentration Vero AS VeroAA HepAS HepAA CTAS CTAA HCCAS HCCAA
0.146 3.109215 1.990551 35.79141 30.35112 12.8377 5.975294 7.783968 8.745881
0.44 5.408872 6.650528 51.02494 37.75747 20.60153 10.73077 11.46489 10.32553
1.33 10.69637 11.36135 71.35304 49.04817 29.12688 22.22418 20.97959 16.96158
4 17.01382 16.88385 85.40934 74.24477 35.73491 40.88149 29.2209 25.64314
11.11 26.49965 24.60198 100.3033 100.0679 53.09883 55.49115 36.44813 30.62045
33.33 45.6563 30.7047 100.5067 100.6611 100.7437 100.3946 98.21393 92.50762





Appendix 2: Percentage cell inhibition against four cell lines by dichloromethane: methanol 
extracts 
Concentration Vero AS VeroAA HepAS HepAA CTAS CTAA HCCAS HCCAA
0.146 0.8.7543418046126.2.884512803339521.10726 30.9613 4.37352 5.83884 7.07493 12.89962
0.44 2.8415793 1.9768973 27.69811 41.8097 8.66742 11.1487 13.6328 17.7897
1.33 6.1542581 4.9122449 38.83832 52.6301 11.1452 15.327 17.2612 26.35619
4 9.9201977 6.0827326 50.07779 60.3073 21.9717 23.8576 23.8725 33.23073
11.11 15.381717 14.544101 79.6383 85.2922 37.6422 39.3352 45.9368 48.52601
33.33 29.942929 22.775279 99.34776 100.074 44.1067 57.1214 61.584 95.28508





Appendix 3: Percentage cell inhibition against four cell lines by dichloromethane extracts 
Concentration Vero AS VeroAA HepAS HepAA CTAS CTAA HCCAS HCCAA
0.146 1.568688 0.607232 13.19412 30.26855 10.20426 12.72226 15.19781 31.65944
0.44 6.678865 4.161618 22.73479 34.17425 22.80155 16.9199 26.64458 36.11432
1.33 11.99676 9.606829 30.73108 40.95545 30.85601 20.1247 35.23833 40.22862
4 18.8007 14.36968 35.14755 45.31353 36.96416 24.23811 47.16388 44.19285
11.11 27.98112 24.57353 48.75756 98.76875 48.06989 45.78486 51.4184 53.14578
33.33 37.21242 33.71729 100.041 100.0071 100.0056 100.1236 100.2887 100.4422





Appendix 4: Percentage cell inhibition against four cell lines by ethyl acetate extracts 
Concentration Vero AS VeroAA HepAS HepAA CTAS CTAA HCCAS HCCAA
0.146 0.231027 0.904217 5.749881 29.01362 14.57699 11.34678 17.7004 13.19061
0.44 4.75939 5.713936 8.551389 32.54415 17.28636 15.70814 21.39388 18.133
1.33 11.75161 11.94548 14.78123 40.91393 25.56982 27.18327 28.98725 25.03783
4 14.08674 14.73363 26.78115 43.68418 31.59973 33.48175 34.40078 32.13801
11.11 28.72646 20.7796 46.72101 59.01005 41.04459 39.99705 45.79794 43.0322
33.33 40.3436 31.5698 100.0976 100.1557 60.61488 59.68164 99.91097 99.58771





Appendix 5: Percentage cell inhibition against four cell lines by Methanol extracts 
Concentration Vero AS VeroAA HepAS HepAA CTAS CTAA HCCAS HCCAA
0.146 0.064629 5.117588 7.9763 16.46567 5.848756 18.68598 3.598511 20.78965
0.44 2.626243 10.66204 11.87596 25.01827 14.75913 27.92778 7.714212 26.72455
1.33 5.683982 14.97508 16.70033 29.2312 22.36342 36.04466 10.15068 32.97834
4 8.791458 19.58329 21.79765 37.03491 26.39888 42.30013 16.4059 47.13884
11.11 15.08628 26.90871 28.76747 48.63545 33.30377 52.36983 27.57141 55.99092
33.33 25.02201 42.42361 36.31202 57.42991 48.08798 84.4163 42.01472 89.96474





Appendix 6: Percentage cell inhibition against four cell lines by Water (aqueous) extracts 
Concentration Vero AS VeroAA HepAS HepAA CTAS CTAA HCCAS HCCAA
0.146 0.183648 0.146814 6.893887 11.58941 15.11442 0.001493 0.712619 10.34706
0.44 0.970823 0.678579 9.186239 17.67058 19.13455 0.970047 3.107263 22.13535
1.33 4.0967 3.752795 18.96768 21.36069 23.92801 4.197933 9.349022 28.592
4 8.908407 7.365114 21.26221 26.27096 29.1807 8.777549 11.19515 33.56486
11.11 15.26641 11.70284 30.58765 32.87458 35.62713 11.50783 20.8576 41.0112
33.33 24.33912 19.25259 35.61668 38.53816 41.26326 15.77658 34.76984 53.43236
100 48.30747 42.0986 64.02359 74.1801 77.50445 37.09513 62.11372 99.52996  
                                        
 
 
